Liminal BioSciences

About:

Liminal is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products.

Website: https://liminalbiosciences.com/

Twitter/X: LiminalBio

Top Investors: Scotiabank, Canaccord Genuity Group, Jefferies, BDC Venture Capital, Thomvest Ventures

Description:

Liminal BioSciences is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products. It specializes in discovering, developing, and commercializing novel small molecule compounds for respiratory, liver, and renal diseases. The company focuses specifically on developing solutions for rare and orphan diseases. Liminal BioSciences was founded in 1992 and is headquartered in Laval, Quebec.

Total Funding Amount:

$150M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Laval, Quebec, Canada

Founded Date:

1992-01-01

Contact Email:

info(AT)prometic.com

Founders:

Pierre Laurin

Number of Employees:

251-500

Last Funding Date:

2020-07-16

IPO Status:

Public

Industries:

© 2025 bioDAO.ai